Somewhat Favorable Media Coverage Somewhat Unlikely to Affect HealthEquity (HQY) Stock Price
News articles about HealthEquity (NASDAQ:HQY) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. HealthEquity earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.5368138301829 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Here are some of the news headlines that may have effected Accern Sentiment’s rankings:
- Darcy G. Mott Sells 9,500 Shares of HealthEquity, Inc. (HQY) Stock (americanbankingnews.com)
- Head to Head Contrast: HealthEquity (HQY) & Its Peers (americanbankingnews.com)
- Robert W. Baird Reaffirms Hold Rating for HealthEquity, Inc. (HQY) (americanbankingnews.com)
- HealthEquity, Inc. breached its 50 day moving average in a Bullish Manner : HQY-US : September 20, 2017 (finance.yahoo.com)
- HealthEquity to Serve Alliant Credit Union HSA Members – GlobeNewswire (press release) (globenewswire.com)
HQY has been the topic of a number of research reports. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Zacks Investment Research cut HealthEquity from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. Cantor Fitzgerald restated a “buy” rating and set a $56.00 price target on shares of HealthEquity in a research note on Tuesday, August 29th. BidaskClub upgraded HealthEquity from a “strong sell” rating to a “sell” rating in a research note on Friday, September 15th. Finally, Chardan Capital upped their price target on HealthEquity from $53.00 to $57.00 and gave the stock a “buy” rating in a research note on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the stock. HealthEquity presently has an average rating of “Buy” and an average target price of $56.50.
Shares of HealthEquity (HQY) opened at 47.35 on Friday. HealthEquity has a 52 week low of $30.34 and a 52 week high of $54.95. The stock has a 50 day moving average price of $44.62 and a 200 day moving average price of $46.01. The firm has a market capitalization of $2.86 billion, a PE ratio of 70.25 and a beta of 1.75.
HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.14 by $0.13. The business had revenue of $56.90 million for the quarter, compared to analyst estimates of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The business’s quarterly revenue was up 28.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.16 EPS. Equities analysts forecast that HealthEquity will post $0.71 earnings per share for the current fiscal year.
In related news, major shareholder Berkley Capital, Llc sold 56,067 shares of HealthEquity stock in a transaction on Monday, June 26th. The shares were sold at an average price of $51.79, for a total transaction of $2,903,709.93. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Stephen Neeleman sold 8,500 shares of HealthEquity stock in a transaction on Monday, July 17th. The shares were sold at an average price of $50.83, for a total transaction of $432,055.00. Following the transaction, the insider now owns 1,000 shares in the company, valued at approximately $50,830. The disclosure for this sale can be found here. Insiders have sold a total of 1,630,567 shares of company stock worth $82,623,514 in the last 90 days. Company insiders own 29.00% of the company’s stock.
WARNING: This piece was posted by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/09/23/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-healthequity-hqy-stock-price.html.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.